文献速递牙体牙髓病口腔修复与种植

减少SARS-CoV-2气溶胶化的牙科缓解策略

Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2.
PubMed 文献 · J Dent Res · 2021-08-02

研究在牙科手术环境中比较空气涡轮机与高速反角手机(HSCAH)在无缓解、强吸和橡皮障下的病毒气溶胶扩散。使用感染Φ6噬菌体的仿生头模型,发现HSCAH可大幅降低沉降生物气溶胶和空气病毒浓度,配合强吸时检测不到噬菌体,提示可取消诊所等待时间。

要点

  • HSCAH较空气涡轮机显著降低沉降生物气溶胶和空气病毒浓度。
  • HSCAH配合强吸时,非飞溅沉降板和术后6-10分钟空气样本均未检出噬菌体。
  • 单独颗粒分析不足以评估生物气溶胶感染风险。

核心结论

  • 使用HSCAH可大幅降低病毒气溶胶化风险,从而无需诊所等待时间。
  • 仅靠颗粒分析不能充分理解生物气溶胶感染风险。

研究设计与样本

  • 在牙科手术环境中,用仿生头模型进行冠预备和根管开髓,分别使用空气涡轮机或HSCAH,并采用橡皮障或强吸及无缓解对照。
  • 人工唾液以1.5 mL min-1流速感染Φ6噬菌体(SARS-CoV-2替代病毒),浓度约10^8 PFU mL-1,反映 reported 唾液SARS-CoV-2水平上限。
  • 用琼脂沉降板、MicroBio MB2空气采样和Kanomax 3889 GEOα粒子计数器测量生物气溶胶扩散、病毒空气浓度和颗粒数量。

主要发现

  • 与空气涡轮机相比,HSCAH在无缓解、强吸和橡皮障下分别减少沉降生物气溶胶99.72%、100.00%和100.00%。
  • 相同缓解条件下,空气噬菌体浓度分别降低99.98%、100.00%和100.00%。
  • HSCAH配合强吸时,非飞溅沉降板和术后6至10分钟空气样本均未检出噬菌体。

临床怎么用

  • 牙科操作中可优先使用HSCAH以降低病毒气溶胶化风险。
  • 配合强吸可进一步减少生物气溶胶,可能取消诊所等待时间。

局限性

  • 该模型代表SARS-CoV-2可能扩散的最坏情况。
  • 使用Φ6噬菌体作为替代病毒,非真实SARS-CoV-2。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Limiting infection transmission is central to the safety of all in dentistry, particularly during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Aerosol-generating procedures (AGPs) are crucial to the practice of dentistry; it is imperative to understand the inherent risks of viral dispersion associated with AGPs and the efficacy of available mitigation strategies. In a dental surgery setting, crown preparation and root canal access procedures were performed with an air turbine or high-speed contra-angle handpiece (HSCAH), with mitigation via rubber dam or high-volume aspiration and a no-mitigation control. A phantom head was used with a 1.5-mL min-1 flow of artificial saliva infected with Φ6-bacteriophage (a surrogate virus for SARS-CoV-2) at ~108 plaque-forming units mL-1, reflecting the upper limits of reported salivary SARS-CoV-2 levels. Bioaerosol dispersal was measured using agar settle plates lawned with the Φ6-bacteriophage host, Pseudomonas syringae. Viral air concentrations were assessed using MicroBio MB2 air sampling and particle quantities using Kanomax 3889 GEOα counters. Compared to an air turbine, the HSCAH reduced settled bioaerosols by 99.72%, 100.00%, and 100.00% for no mitigation, aspiration, and rubber dam, respectively. Bacteriophage concentrations in the air were reduced by 99.98%, 100.00%, and 100.00% with the same mitigations. Use of the HSCAH with high-volume aspiration resulted in no detectable bacteriophage, both on nonsplatter settle plates and in air samples taken 6 to 10 min postprocedure. To our knowledge, this study is the first to report the aerosolization in a dental clinic of active virus as a marker for risk determination. While this model represents a worst-case scenario for possible SARS-CoV-2 dispersal, these data showed that the use of HSCAHs can vastly reduce the risk of viral aerosolization and therefore remove the need for clinic fallow time. Furthermore, our findings indicate that the use of particle analysis alone cannot provide sufficient insight to understand bioaerosol infection risk.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Vernon JJ, Black EVI, Dennis T, et al. Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2. J Dent Res. 2021. PMID: 34338580. doi:10.1177/00220345211032885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。